• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期自然主义治疗中情绪障碍患者的辍学率及相关因素

The Dropout Rates and Associated Factors in Patients with Mood Disorders in Long-term Naturalistic Treatment.

作者信息

Jung Wooyoung, Moon Eunsoo, Lim Hyun Ju, Park Je Min, Lee Byung Dae, Lee Young Min, Jeong Heejeong, Suh Hwagyu, Kim Kyungwon

机构信息

Jung Wooyoung Psychiatry Clinic, Busan, Korea.

Department of Psychiatry and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.

出版信息

Clin Psychopharmacol Neurosci. 2024 May 31;22(2):263-275. doi: 10.9758/cpn.23.1089. Epub 2023 Jul 27.

DOI:10.9758/cpn.23.1089
PMID:38627073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11024694/
Abstract

OBJECTIVE

Although maintenance treatment for mood disorders is important, the treatment discontinuation rate is reported to be high. This study aimed to investigate the dropout rates and associated factors in mood disorders.

METHODS

The patients in a mood disorder clinic (n = 535) were examined. Demographic and clinical factors, scores of psychometric scales, time to dropout from initial treatment in patients with bipolar disorder (BP) (n = 288) and depressive disorder (DD) (n = 143) were evaluated based on database of the mood disorder clinic.

RESULTS

Among the studied patients with BP and DD, 50% showed dropout in 4.05 and 2.17 years, respectively. The mean survival times were 8.90 years in bipolar disorder I (BP-I), 5.19 years in bipolar II disorder, 3.22 years in bipolar disorder not otherwise specified, 4.24 years in major depressive disorder, and 4.03 years in other depressive disorders. In the multivariate Cox proportional hazards regression model in the BP group, diagnosis BP-I was found to be significantly related to the decrease in dropout rate (hazard ratio [HR] = 0.22, = 0.001); however, increased past suicide attempt number was significantly related to the increase in dropout rate (HR = 1.13, = 0.017). In the DD group, none of anxiety disorders as comorbidity, increased scores of openness, and extraversion personality were related to the increase in dropout rate.

CONCLUSION

Patients with BP, especially BP-I, showed a lower dropout rate as compared to patients with other mood disorders.

摘要

目的

尽管情绪障碍的维持治疗很重要,但据报道治疗中断率很高。本研究旨在调查情绪障碍的脱落率及相关因素。

方法

对一家情绪障碍诊所的患者(n = 535)进行了检查。基于该情绪障碍诊所的数据库,评估了人口统计学和临床因素、心理测量量表得分、双相情感障碍(BP)患者(n = 288)和抑郁症(DD)患者(n = 143)从初始治疗开始的脱落时间。

结果

在研究的BP和DD患者中,分别有50%在4.05年和2.17年出现脱落。双相I型障碍(BP-I)的平均生存时间为8.90年,双相II型障碍为5.19年,未另行指定的双相情感障碍为3.22年,重度抑郁症为4.24年,其他抑郁症为4.03年。在BP组的多变量Cox比例风险回归模型中,发现诊断为BP-I与脱落率降低显著相关(风险比[HR]=0.22,P = 0.001);然而,既往自杀未遂次数增加与脱落率增加显著相关(HR = 1.13,P = 0.017)。在DD组中,合并焦虑障碍、开放性得分增加和外向型人格均与脱落率增加无关。

结论

与其他情绪障碍患者相比,BP患者,尤其是BP-I患者的脱落率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e8f/11024694/292e5c9ae1de/cpn-22-2-263-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e8f/11024694/292e5c9ae1de/cpn-22-2-263-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e8f/11024694/292e5c9ae1de/cpn-22-2-263-f1.jpg

相似文献

1
The Dropout Rates and Associated Factors in Patients with Mood Disorders in Long-term Naturalistic Treatment.长期自然主义治疗中情绪障碍患者的辍学率及相关因素
Clin Psychopharmacol Neurosci. 2024 May 31;22(2):263-275. doi: 10.9758/cpn.23.1089. Epub 2023 Jul 27.
2
Dropout rate and associated factors in patients with bipolar disorders.双相情感障碍患者的辍学率及相关因素。
J Affect Disord. 2012 Dec 1;141(1):47-54. doi: 10.1016/j.jad.2012.02.025. Epub 2012 Mar 10.
3
Feasibility and Acceptability of Group Interpersonal and Social Rhythm Therapy for Recurrent Mood Disorders: A Pilot Study.团体人际与社会节律疗法对复发性心境障碍的可行性与可接受性:一项初步研究
Am J Psychother. 2024 Mar 15;77(1):1-6. doi: 10.1176/appi.psychotherapy.20220067. Epub 2023 Nov 28.
4
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.在一项对照家族研究中,主要抑郁障碍和双相情感障碍与大麻使用障碍的共病和共聚集。
JAMA Psychiatry. 2022 Jul 1;79(7):727-735. doi: 10.1001/jamapsychiatry.2022.1338.
5
Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients.患有饮食失调症的抑郁症患者中单相和双相情感障碍共病时的相关特征及药物治疗比较。
BMC Psychiatry. 2017 Feb 27;17(1):81. doi: 10.1186/s12888-017-1243-0.
6
The profile and familiality of personality traits in mood disorder families.心境障碍家族的人格特质特征和家族性。
J Affect Disord. 2012 May;138(3):367-74. doi: 10.1016/j.jad.2012.01.015. Epub 2012 Feb 12.
7
Classifying mood disorders by age-at-onset instead of polarity.根据发病年龄而非极性对情绪障碍进行分类。
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):86-93. doi: 10.1016/j.pnpbp.2008.10.007. Epub 2008 Oct 27.
8
Bipolar II disorder : epidemiology, diagnosis and management.双相II型障碍:流行病学、诊断与管理
CNS Drugs. 2007;21(9):727-40. doi: 10.2165/00023210-200721090-00003.
9
Phenomenology of psychotic mood disorders: lifetime and major depressive episode features.精神病性心境障碍的现象学:终身和重度抑郁发作的特征。
J Affect Disord. 2011 Dec;135(1-3):241-50. doi: 10.1016/j.jad.2011.07.027. Epub 2011 Sep 1.
10
Bipolar II with and without cyclothymic temperament: "dark" and "sunny" expressions of soft bipolarity.伴有或不伴有环性心境气质的双相II型障碍:软双相的“阴暗”与“阳光”表现
J Affect Disord. 2003 Jan;73(1-2):49-57. doi: 10.1016/s0165-0327(02)00320-8.

本文引用的文献

1
Prediction of the Duration to Next Admission for an Acute Affective Episode in Patients with Bipolar I Disorder.双相I型障碍患者急性情感发作至下次入院时间的预测
Clin Psychopharmacol Neurosci. 2023 May 30;21(2):262-270. doi: 10.9758/cpn.2023.21.2.262.
2
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review.关于抑郁症患者减停抗抑郁药物的临床实践指南建议:一项系统评价
Ther Adv Psychopharmacol. 2022 Feb 11;12:20451253211067656. doi: 10.1177/20451253211067656. eCollection 2022.
3
Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression- an Asian Sub-group Analysis from the SUSTAIN-2 Study.
艾氯胺酮鼻腔喷雾剂联合口服抗抑郁药治疗难治性抑郁症患者的长期安全性和有效性——来自SUSTAIN-2研究的亚洲亚组分析
Clin Psychopharmacol Neurosci. 2022 Feb 28;20(1):70-86. doi: 10.9758/cpn.2022.20.1.70.
4
The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines.《2021年韩国抑郁症药物治疗算法项目:与其他治疗指南的比较》
Clin Psychopharmacol Neurosci. 2022 Feb 28;20(1):37-50. doi: 10.9758/cpn.2022.20.1.37.
5
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression.单相和双相抑郁症门诊患者早期退出相关的临床特征。
J Psychiatr Res. 2021 Apr;136:522-528. doi: 10.1016/j.jpsychires.2020.10.025. Epub 2020 Oct 22.
6
How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist.如何提高重度抑郁症患者对抗抑郁治疗的依从性:一份心理教育共识清单。
Ann Gen Psychiatry. 2020 Oct 12;19:61. doi: 10.1186/s12991-020-00306-2. eCollection 2020.
7
Pharmacological Treatments for Patients with Treatment-Resistant Depression.难治性抑郁症患者的药物治疗
Pharmaceuticals (Basel). 2020 Jun 4;13(6):116. doi: 10.3390/ph13060116.
8
Evaluation of Eating Attitudes, Anger and Impulsivity in Atypical and Non-Atypical Depression and Assessment of Comorbidity of Binge Eating.非典型与非非典型抑郁症患者进食态度、愤怒和冲动的评估及暴食症共病的评估。
Psychiatr Danub. 2020 Spring;32(1):105-114. doi: 10.24869/psyd.2020.105.
9
Individual and Gender Differences in Personality Influence the Diagnosis of Major Depressive Disorder.人格的个体差异和性别差异影响重度抑郁症的诊断。
Psychiatr Danub. 2020 Spring;32(1):97-104. doi: 10.24869/psyd.2020.97.
10
Multidimensional Scale of Perceived Social Support in Indonesian adolescent disaster survivors: A psychometric evaluation.印度尼西亚青少年灾难幸存者感知社会支持多维量表:心理测量评估。
PLoS One. 2020 Mar 13;15(3):e0229958. doi: 10.1371/journal.pone.0229958. eCollection 2020.